BOOTHBAY FUND MANAGEMENT, LLC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is and the CUSIP is 75615P953. A total of 5 filers reported holding REATA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BOOTHBAY FUND MANAGEMENT, LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$1,196,000
-43.4%
120
-29.8%
0.04%
-43.0%
Q4 2020$2,114,000
+267.7%
171
+189.8%
0.08%
+125.7%
Q3 2020$575,000
-64.9%
59
-43.8%
0.04%
-68.8%
Q2 2020$1,638,000
-3.8%
105
-11.0%
0.11%
-20.6%
Q1 2020$1,703,000
+259.3%
118
+100.0%
0.14%
+227.9%
Q3 2019$474,000
-14.9%
590.0%0.04%
-15.7%
Q2 2019$557,000
+10.5%
590.0%0.05%
+4.1%
Q1 2019$504,000590.05%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Sofinnova Investments, Inc. 60,000$5,845,0000.43%
BOOTHBAY FUND MANAGEMENT, LLC 59$575,0000.04%
GROUP ONE TRADING, L.P. 3,600$351,0000.00%
SIMPLEX TRADING, LLC 60$584,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of REATA PHARMACEUTICALS INC shareholders